Alkem Foundation Partners with IIT Bombay to Establish India's First Immunotherapy Research Centre
核心洞察
Alkem Foundation (搜索) and IIT Bombay announce a strategic collaboration to establish India's first research centre dedicated to immuno-therapeutics (搜索) and regenerative medicines (搜索).
The partnership represents the country's first industry-academia CSR initiative in this field, with Alkem Foundation (搜索) committing 20-25% of its CSR obligations over seven years.
The new centre will focus on developing high-precision therapies including cell and gene therapy (搜索), gene editing (搜索), and advanced delivery platforms for complex diseases (搜索) with unmet medical needs.
Alkem Foundation (搜索), the Corporate Social Responsibility arm of Alkem Laboratories Ltd. (搜索), has announced a groundbreaking strategic collaboration with the Indian Institute of Technology Bombay (搜索) (IIT Bombay) to establish India's first research centre dedicated to immuno-therapeutics (搜索) and regenerative medicines (搜索). This partnership marks a significant milestone as the country's first industry-academia collaboration initiated through the CSR route in these critical therapeutic areas.
Substantial Investment in Medical Innovation
Under the collaboration, Alkem Foundation (搜索) will fund the establishment of the "Alkem Centre for Advanced Research in Applied Immuno-Therapeutics (搜索) and Regenerative Medicines (搜索)" at the IIT Bombay campus. The foundation has committed to contribute a substantial 20-25% of its cumulative CSR obligations over seven years to support this initiative, representing a pioneering step in fostering cutting-edge research in complex disease areas with significant unmet medical needs.
Combining Industry Expertise with Academic Excellence
The partnership strategically combines Alkem's pharmaceutical industry insights and experience in developing healthcare solutions with IIT Bombay's expertise in biomedical engineering, biosciences, and translational research. The collaboration leverages the institute's pool of globally trained faculty to create a distinctive innovation and translation ecosystem.
"At Alkem, we understand the critical role of scientific advancement and transformative research in addressing unmet medical needs," said Madhurima Singh, Executive Director and Chairperson of the CSR and Sustainability Committee at Alkem. "Despite government encouragement, only a small share of corporate CSR spending in India goes towards R&D. We saw it as our responsibility to go beyond business and support R&D in the important field of immuno-therapeutics (搜索) and regenerative medicines (搜索) through CSR."
Comprehensive Research Focus Areas
The new research centre is being developed to build a comprehensive ecosystem that enables innovation, research, and skill development in complex and underserved therapy areas. The centre will focus on advancing several key areas:
- Immuno-therapeutics
- Regenerative medicine
- Cell and gene therapy
- Gene editing and biomaterials
- Advanced delivery and therapeutic engineering platforms
Building on IIT Bombay's strong foundation in biotechnology, biomedical engineering, and regenerative sciences, the centre will expand into emerging areas using unique models based on futuristic techniques for delivery and edition.
Training and Development Hub
The centre will serve as a training and incubation hub for clinician-scientists and biotech entrepreneurs, strengthening India's translational research ecosystem in life sciences. It will draw upon IIT Bombay's core faculty and have mentors from both IIT Bombay and Alkem, as well as global experts from premier universities who will advise on the research programmes.
Prof. Shireesh B. Kedare, Director of IIT Bombay, emphasized the collaboration's potential impact: "This collaboration will foster clinical breakthroughs that lead to affordable therapies, reduce dependence on imports, and take us a step further in India's journey toward self-reliance in healthcare innovation."
Setting a National Benchmark
According to the partnership announcement, IIT Bombay and Alkem Foundation (搜索) aim to create a national model for industry-academia partnerships that advance affordable, high-impact healthcare innovation. The collaboration seeks to position India as a global leader in applied biotechnology and precision medicine while developing healthcare solutions "by India, for India and the world."
The initiative augments IIT Bombay's multidisciplinary approach to healthcare, integrating biology, engineering, and data science to advance human health. The institute's pioneering research spans biotechnology, biomedical engineering, and cell and gene therapy (搜索), forming the foundation for next-generation immuno-therapeutics (搜索) and regenerative medicine.